Market Research Report
Agricultural Biotechnology: Emerging Technologies and Global Markets
|Published by||BCC Research||Product code||247685|
|Published||Content info||190 Pages
|Agricultural Biotechnology: Emerging Technologies and Global Markets|
|Published: November 19, 2014||Content info: 190 Pages||
The global market for agricultural biotechnology reached $26.4 billion in 2013 and $27.8 billion in 2014. This indication is expected to reach $46.8 billion in 2019, registering a compound annual growth rate (CAGR) of 11.0% over the next five years.
The scope of the report includes key agricultural biotechnology tools (i.e., next-generation DNA sequencing, biochips, RNA interference, synthetic biology tools and genome editing tools); synthetic biology-enabled chemicals and biofuels; transgenic seeds; and biologicals.
BCC Research analyzes these technologies and products to determine the present and future markets and the future applications of agricultural biotechnologies in the major market segments, and to forecast global growth and revenues from 2014 through 2019. The report also discusses industry structure and strategic alliances, competitive dynamics, patent situation and forces driving the market.
BCC Research provides in-depth coverage of the agricultural biotechnology industry structure, including agricultural biotechnology research initiatives, the seed genomics industry, biotech traits industry, synthetic biology industry, genome editing industry, agricultural biologics industry, and industry acquisitions and strategic alliances.
John Bergin is the author of previous BCC Research biotechnology reports titled Next Generation Sequencing: Emerging Clinical Applications and Global Markets; Epigenomics: Emerging Opportunities in Biomarkers, Diagnostics and Therapeutics; Global Biochip Markets: Microarrays and Lab-on-a-chip; RNA Interference in the Post-Genomics Era: Markets and Technologies; DNA Sequencing: Emerging Technologies and Applications; Biologic Imaging Reagents: Technologies and Global Markets; and Synthetic Biology: Emerging Global Markets.
Mr. Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with a separations technology company. He holds a B.S. in Chemistry, an M.S. in Biotechnology and an MBA.